MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-BR-26-0042534
KND Pharmaceuticals Private Limited
KND Pharmaceuticals Private Limited - trading in Ghaziabad, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.12 Cr
▲ 7% YoY
Net profit · FY 2025
₹2.43 Lakh
Net margin 2.2%
EBITDA · FY 2025
₹5.36 Lakh
EBITDA margin 4.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹32 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About KND Pharmaceuticals Private Limited
Data last updated:
KND Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 01 October 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51909UP2021PTC153247. Its GSTIN is 10AAJCK0621K1ZY (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Komal Kumari and Saroj Devi.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 713 3rd Floor Sector 3F Vaishali Ghaziabad, Uttar Pradesh, India – 201010.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.12 Cr, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹2.43 Lakh (net margin 2.2%) and EBITDA of ₹5.36 Lakh (EBITDA margin 4.8%).
As per MCA filings, the company has open charges of ₹32 Lakh on record.
KND Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0042534).
Company details
CIN U51909UP2021PTC153247
Registration Number 153247
Incorporation Date 01 October 2021
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0042534
Key People
Komal Kumari Director Saroj Devi Director Recognitions & Rankings of KND Pharmaceuticals
Contact details
KND Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered Address713 3rd Floor Sector 3F Vaishali Ghaziabad, Uttar Pradesh, India – 201010
- IndustryTrading, Specialty, Wholesale
To see the full contact details of KND Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
KND Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of KND Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of KND Pharmaceuticals Private Limited, buy the company report.
Financials of KND Pharmaceuticals Private Limited
FY 2025 filings availableKND Pharmaceuticals Private Limited reported revenue of ₹1.12 Cr (up 7% YoY) for FY 2025.
Revenue · FY 2025
₹1.12 Cr ▲ 7%
Net profit · FY 2025
₹2.43 Lakh margin 2.2%
EBITDA · FY 2025
₹5.36 Lakh margin 4.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 7%
EBITDA CAGR growth
1 year
▲ 61%
3 years · compounded
▲ 229%
Revenue rose 7% in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹5.36 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.43 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 4.8% | |||
| Net Profit Margin | 2.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of KND Pharmaceuticals Private Limited, buy the company report.
Board of directors of KND Pharmaceuticals Private Limited
KND Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Komal Kumari Also directs: KND Welfare Foundation | Director | 01 Oct 2021 | 5 Years 0 Months | Current |
| Saroj Devi | Director | 01 Oct 2021 | 5 Years 0 Months | Current |
Peer comparison
KND Pharmaceuticals Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cospex Pharmaceuticals Private Limited | ₹1.13 Cr (FY 2024) | -11.0% | Manimajra, Chandigarh, India | |||
| Exalt Pharmaceuticals Private Limited | ₹1.13 Cr (FY 2025) | -25.0% | Faridabad, Haryana, India | |||
| Servigen Pharmaceuticals Private Limited | ₹1.13 Cr (FY 2025) | 14.0% | New Delhi, Delhi, India | |||
| Ambiens Pharmaceuticals Private Limited | ₹1.12 Cr (FY 2025) | 119.0% | Csa, Uttar Pradesh, India | |||
| Anglo-Indian Pharmaceuticals Private Limited | ₹1.12 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| KND Pharmaceuticals Private Limitedthis company | ₹1.12 Cr (FY 2025) | ₹2.43 Lakh | 2.2% | 7.0% | Ghaziabad, Uttar Pradesh, India | |
| Vijayasudha Pharmaceuticals Private Limited | ₹1.12 Cr (FY 2023) | -26.0% | Hyderabad, Telangana, India | |||
| Tricent Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | 7056835.0% | Lucknow, Uttar Pradesh, India | |||
| Cellestus Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | 122.0% | Baddi, Himachal Pradesh, India | |||
| Saudavel Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2025) | -32.0% | Margao, Goa, India |
To see the full peer comparison of KND Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹32 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 May 2024 | 100955766 | Others | ₹32 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving KND Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for KND Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
KND Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 05, 2024.
Active EPFO establishments
1
GST
KND Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAJCK0621K1ZY | Bihar | Active | 16 Mar 2022 |
To see the full GST registrations and return filing status of KND Pharmaceuticals Private Limited, buy the company report.
Recent activity
KND Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Komal Kumari was appointed as Director on 01 Oct 2021.
AGM
Knd Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Knd Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
A charge with Others amounted to Rs. 32.00 Lakh with Charge ID 100955766 was registered on 14 May 2024.
Appointed
Komal Kumari was appointed as Director.
Appointed
Saroj Devi was appointed as Director.
Incorporation
01 Oct 2021
Knd Pharmaceuticals Private Limited was registered on 01 Oct 2021 with Roc Kanpur & aged 5 years 26 days as per MCA records.
Frequently asked questions
KND Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 01 October 2021 (5+ years old) and is registered under CIN U51909UP2021PTC153247.
KND Pharmaceuticals has 2 current directors:
- Komal Kumari - Director
- Saroj Devi - Director
The latest financial statements of KND Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of KND Pharmaceuticals is 10AAJCK0621K1ZY, registered in Bihar.
The CIN (Corporate Identification Number) of KND Pharmaceuticals is U51909UP2021PTC153247. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
KND Pharmaceuticals was incorporated on 01 October 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of KND Pharmaceuticals by revenue are Cospex Pharmaceuticals Private Limited, Exalt Pharmaceuticals Private Limited, Servigen Pharmaceuticals Private Limited, Ambiens Pharmaceuticals Private Limited, Anglo-Indian Pharmaceuticals Private Limited and 4 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Komal Kumari was appointed as Director on 01 Oct 2021. Saroj Devi was appointed as Director on 01 Oct 2021.
Yes, KND Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0042534).
The registered office of KND Pharmaceuticals is at 713 3rd Floor Sector 3F Vaishali Ghaziabad, Uttar Pradesh, India – 201010.
KND Pharmaceuticals operates in the trading industry, in the specialty segment.